Meeting on Responsible Innovation in Dietary Supplements

FDA has announced a 5/16 public meeting entitled “Responsible Innovation in Dietary Supplements.” The meeting is intended to provide interested parties an opportunity to present ideas for facilitating responsible innovation in the dietary supplement industry while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products. The following topics will be discussed at the meeting: 

• The scope of the phrase “dietary substance for use by man to supplement the diet by increasing the total dietary intake”
• Understanding exceptions to the requirement for premarket notification, and evaluating whether and how growth in the marketplace since 1994 has altered the impact of those provisions
• Potential commercial or marketing advantages to incentivize responsible innovation
• Promoting overall compliance with the premarket notification requirement through enforcement